Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a method of treating or preventing musculoskeletal pain in a mammal receiving administration of an estrogen. suppressant selected from the group consisting of aromatase inhibitors, GnRH analogues, cyclo-oxy-genase 2 (COX-2) inhibitors, 17β-hydroxysteroid dehydrogenase type 1 inhibitors, progestogens, anti-estrogens and combinations thereof, said method comprising the administration of an effective amount of an estrogenic component, wherein the estrogenic component is selected from the group consisting of: substances represented by the following formula (1) in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and/or precursors.
-
Citations
24 Claims
-
1-12. -12. (canceled)
-
13. A method of treating or preventing musculoskeletal pain in a mammal receiving administration of an estrogen suppressant selected from the group consisting of aromatase inhibitors, GnRH analogues, cyclo-oxygenase 2 (COX-2) inhibitors, 17β
- -hydroxysteroid dehydrogenase type 1 inhibitors, progestogens, anti-estrogens and combinations thereof, said method comprising administering an estrogenic component in an effective amount to prevent said musculoskeletal pain, said estrogenic component being selected from the group consisting of;
substances represented by the following formula in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms;
precursors capable of liberating a substance according to the aforementioned formula when used in the present method, which precursors are derivatives of the estrogenic substances wherein the hydrogen atom of at least one of the hydroxyl groups has been substituted by an acyl radical of a hydrocarbon carboxylic, sulfonic acid or sulfamic acid of 1-25 carbon atoms;
tetrahydrofuranyl;
tetrahydropyranal;
or a straight or branched chain glycosydic residue containing 1-20 glycosidic units per residue; and
mixtures of one or more of the aforementioned substances and/or precursors. - View Dependent Claims (14, 15, 16, 19, 20, 21, 22, 23, 24)
- -hydroxysteroid dehydrogenase type 1 inhibitors, progestogens, anti-estrogens and combinations thereof, said method comprising administering an estrogenic component in an effective amount to prevent said musculoskeletal pain, said estrogenic component being selected from the group consisting of;
- 17. Method according to claim 17, wherein the estrogenic component is administered orally, intranasally, transdermally, subcutaneously, intramuscularly, intravenously, intravaginally, intrauterinely, pulmonary, rectally or buccally.
Specification